Recruitment to multicentre trials—lessons from UKCTOCS: descriptive study

Objective To describe the factors that contributed to successful recruitment of more than 200 000 women to the UK Collaborative Trial of Ovarian Cancer Screening, one of the largest ever randomised controlled trials. Design Descriptive study. Setting 13 NHS trusts in England, Wales, and Northern Ireland. Participants Postmenopausal women aged 50-74; exclusion criteria included ovarian malignancy, bilateral oophorectomy, increased risk of familial ovarian cancer, active non-ovarian malignancy, and participation in other ovarian cancer screening trials. Main outcome measures Achievement of target recruitment, acceptance rates of invitation, and recruitment rates. Results The trial was set up in 13 centres with 27 adjoining local health authorities. The coordinating centre team was led by one of the senior investigators, who was closely involved in planning and day to day trial management. Of 1 243 282 women invited, 23.2% (288 955) replied that they were eligible and would like to participate. Of those sent appointments, 73.6% (205 090) attended for recruitment. The acceptance rate varied from 19% to 33% between trial centres. Measures to ensure target recruitment included named coordinating centre staff supporting and monitoring each centre, prompt identification and resolution of logistic problems, varying the volume of invitations by centre, using local non-attendance rates to determine the size of recruitment clinics, and organising large ad hoc clinics supported by coordinating centre staff. The trial randomised 202 638 women in 4.3 years. Conclusions Planning and trial management are as important as trial design and require equal attention from senior investigators. Successful recruitment needs constant monitoring by a committed proactive management team that is willing to explore individual solutions for different centres and use central resources to improve local recruitment. Automation of trial processes with web based trial management systems is crucial in large multicentre randomised controlled trials. Recruitment can be further enhanced by using information videos and group discussions. Trial registration Current Controlled Trials ISRCTN22488978.

[1]  T. Lang,et al.  Could an Open-Source Clinical Trial Data-Management System Be What We Have All Been Looking For? , 2008, PLoS medicine.

[2]  N. Stocks,et al.  Seminars may increase recruitment to randomised controlled trials: lessons learned from WISDOM , 2008, Trials.

[3]  M. Parmar,et al.  Decline in use of hormone therapy among postmenopausal women in the United Kingdom , 2007, Menopause.

[4]  Michael Waller,et al.  Effect of mammographic screening from age 40 years on breast cancer mortality at 10 years' follow-up: a randomised controlled trial , 2006, The Lancet.

[5]  S. Boles,et al.  Successful participant recruitment strategies for an online smokeless tobacco cessation program. , 2006, Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco.

[6]  Claire Snowdon,et al.  Does it matter if clinicians recruiting for a trial don't understand what the trial is really about? Qualitative study of surgeons' experiences of participation in a pragmatic multi-centre RCT , 2007, Trials.

[7]  J. Twiss,et al.  Challenges of Recruitment of Breast Cancer Survivors to a Randomized Clinical Trial for Osteoporosis Prevention , 2006, Cancer nursing.

[8]  Steven J Skates,et al.  Prospective study using the risk of ovarian cancer algorithm to screen for ovarian cancer. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[9]  C. Thomson,et al.  A cross-sectional analysis demonstrated the healthy volunteer effect in smokers. , 2005, Journal of clinical epidemiology.

[10]  J. Faivre,et al.  Cancer prone persons. A randomized screening trial based on colonoscopy: background, design and recruitment , 2004, Familial Cancer.

[11]  E. Lesaffre,et al.  Mammography screening attendance: meta-analysis of the effect of direct-contact invitation. , 2003, American journal of preventive medicine.

[12]  J. Wardle,et al.  Single flexible sigmoidoscopy screening to prevent colorectal cancer: baseline findings of a UK multicentre randomised trial , 2002, The Lancet.

[13]  J. Wardle,et al.  Design of a multicentre randomised trial to evaluate flexible sigmoidoscopy in colorectal cancer screening , 2001, Journal of medical screening.

[14]  J. Cambron Recruitment and accrual of women in a randomized controlled trial of spinal manipulation. , 2001, Journal of manipulative and physiological therapeutics.

[15]  P C Prorok,et al.  Design of the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial. , 2000, Controlled clinical trials.

[16]  Liam D. Turner,et al.  Design and evolution of the data management systems in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial. , 2000, Controlled clinical trials.

[17]  C. Pennington,et al.  Screening sigmoidoscopy: a randomised trial of invitation style. , 2000, Health bulletin.

[18]  The ESUB-MG Study Group The Million Women Study: design and characteristics of the study population , 1999, Breast Cancer Research.

[19]  S. Melamed,et al.  Healthy volunteer effect in industrial workers. , 1999, Journal of clinical epidemiology.

[20]  D. Oram,et al.  A comparison of national cancer registry and direct follow-up in the ascertainment of ovarian cancer , 1999, British Journal of Cancer.

[21]  Steven J Skates,et al.  Screening for ovarian cancer: a pilot randomised controlled trial , 1999, The Lancet.

[22]  N. Borhani,et al.  Mass mailing and staff experience in a total recruitment program for a clinical trial: the SHEP experience. Systolic Hypertension in the Elderly Program. Cooperative Research Group. , 1999, Controlled clinical trials.

[23]  R. Prescott,et al.  Factors that limit the quality, number and progress of randomised controlled trials. , 1999, Health technology assessment.

[24]  B. Farrell Efficient management of randomised controlled trials: nature or nurture , 1998, BMJ.

[25]  J. Wardle,et al.  Uptake, yield of neoplasia, and adverse effects of flexible sigmoidoscopy screening , 1998, Gut.

[26]  I. Jacobs,et al.  Risk of diagnosis of ovarian cancer after raised serum CA 125 concentration: a prospective cohort study , 1996, BMJ.

[27]  W. L. Beeson,et al.  Healthy volunteer effect in a cohort study: temporal resolution in the Adventist Health Study. , 1996, Journal of clinical epidemiology.

[28]  T. Bourne,et al.  Feasibility Study of a Randomised Trial of Ovarian Cancer Screening among the General Population , 1994, Journal of medical screening.

[29]  J. Grudzinskas,et al.  Prevalence screening for ovarian cancer in postmenopausal women by CA 125 measurement and ultrasonography. , 1993, BMJ.

[30]  Isabel Stabile,et al.  MULTIMODAL APPROACH TO SCREENING FOR OVARIAN CANCER , 1988, The Lancet.